Annual Drug Patent Expirations for RYANODEX
Ryanodex is a drug marketed by Eagle Pharms and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.
Drug patent litigation for RYANODEX.
This drug has eight patent family members in five countries.
The generic ingredient in RYANODEX is dantrolene sodium. One supplier is listed for this compound. Additional details are available on the dantrolene sodium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published at New patent for Eagle Pharms drug RYANODEX
